Investigation of the Safety of an HIV-1 Vaccine Given Intra-muscularly and Intra-nasally to Healthy Female Subjects

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2010
This study is designed to investigate the safety and efficacy of a newly developed vaccine against HIV-1 in female healthy subjects. Safety will be assessed by local and systemic adverse reactions, investigations of blood and urine, and physical exam including vital sign measurements. Efficacy will be assessed in blood, and in vaginal and rectal mucosal samples.
Epistemonikos ID: 23e2e265ce2deeca6afe3e31f47497406f04244e
First added on: Dec 01, 2021